ULURU Inc. announced unaudited consolidated earnings results for the fourth quarter and audited consolidated earnings results for the year ended December 31, 2014. For the quarter, the company reported total revenues of $229,799 against $129,060 a year ago. Loss before income taxes was $318,028 against income before income taxes of $858,270 a year ago. Net income was $318,028 against net loss of $858,270 a year ago. Net income allocable to common stockholders was $318,028 against net loss allocable to common stockholders of $858,270 a year ago. Basic and diluted net earnings per common share were $0.01 against basic and diluted net loss per common share of $0.04 a year ago. Operating loss was $811,987 against $751,828 a year ago. The increase of approximately $101,000 in revenues from the fourth quarter of 2014 compared to the fourth quarter of 2013 was primarily due to an increase of $99,000 from the sale of Altrazeal to international distributors.

For the year, the company reported total revenues of $863,857 against $370,568 a year ago. Loss before income taxes was $1,938,837 against $3,080,914 a year ago. Net loss was $1,938,837 against $3,080,914 a year ago. Net loss allocable to common stockholders was $1,938,837 against $3,111,150 a year ago. Basic and diluted net loss per common share was $0.08 against $0.21 a year ago. Operating loss was $2,904,704 against $2,647,698 a year ago. The increase of approximately $493,000 in Revenue was due principally to an increase of $450,000 in Altrazeal product sales to international distributors and an increase of $33,000 in royalties related to Altrazeal sales by international distributors.